High Prices Could Limit Minnesota Medical Cannabis Market

Minnesota’s medical marijuana market could be smaller than expected, as patients will reportedly have to shell out between $100 and $500 a month for medicine.

The two companies designated by the state government to sell cannabis-infused products have pledged to “set up special pricing structures” for lower-income patients, the Associated Press reported.

But even so, average costs could deter patients from signing up for the program, or push them toward the black market.

One of the licensed companies, Minnesota Medical Solutions (MinnMed), said a patient can expect to pay between $100 and $500 a month for its products, while the other, LeafLine, will likely offer a month’s supply of cannabis-based medicine for between $250 and $500, according to the AP.

The high pricetags are a direct result of state regulations that prohibit smokeable marijuana and require cannabis to be converted into pills, oils or vapors. Also adding to the cost are tight security requirements, along with transportation costs from production facilities to dispensaries.

MinnMed said it is planning on instituting a pricing scale based on income to aid patients with lower incomes. Those below the federal poverty level can qualify for up to 60% off, and those who make up to double the federal poverty level can get up to 30% off.

LeafLine, meanwhile, is still trying to figure out how to lower its prices for low-income patients in need.

Minnesota dispensaries are slated to open starting July 1.

One comment on “High Prices Could Limit Minnesota Medical Cannabis Market
  1. Lee on

    Who’s really surprised that the cost to potential patients is high. With only 2 companies allowed to grow a n distribute, and several lawmakers that pushed for passage, now on the distribution patroll, it was set up in the beginning to be a highly profitable venture, protected by laws written by the sellers. As a terminally ill cancer patient myself, dependent on ever increasing oxycodin to relieve chronic pain, and unable to maintain an appetite causing reduced weight, I had hopes of even mild improvement in pain management and increased appetite. The search for only profits has excluded me from any benefits that might have come from medical cannabis. Once again, corporate profit, have trumped patient care. Limited distribution has all but assured those that might truly benefit w will not have access. The only solution is to expose truly sick cancer patients, to illegal purchases from the criminal element and risk arrest and danger from unscrupulous pot dealers. The Governor and Cheifs of police are turning very ill Minnestoans into criminals. We had expected better from our elected officials. We got profit seekers, with little concern for some of the most ill Minnestoans, a shameful exobition of a lack of compassion, and disrespect for anything other that profits at the expense of suffering cancer patients. In other words, business as usual at our state capital by our so concerned legislators.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *